Burt, Alastair D.

Publishing since 1981 (Dinosaur)

Has published 123 publications in 30 years

Number of publications published per year by Burt, Alastair D.. (Source : PubMed)

Distribution of publications types for Burt, Alastair D.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Harte AL, da Silva NF, Creely SJ, McGee KC, Billyard T, Youssef-Elabd EM, Tripathi G, Ashour E, Abdalla MS, Sharada HM, Amin AI, Burt AD, Kumar S, Day CP, McTernan PG. Elevated endotoxin levels in non-alcoholic fatty liver disease.  Journal of inflammation (London, England)  2010;7;1  
•  Gieling RG, Elsharkawy AM, Caamaño JH, Cowie DE, Wright MC, Ebrahimkhani MR, Burt AD, Mann J, Raychaudhuri P, Liou HC, Oakley F, Mann DA. The c-Rel subunit of nuclear factor-kappaB regulates murine liver inflammation, wound-healing, and hepatocyte proliferation.  Hepatology  2010;51;3  
•  Dongiovanni P, Valenti L, Rametta R, Daly AK, Nobili V, Mozzi E, Leathart JB, Pietrobattista A, Burt AD, Maggioni M, Fracanzani AL, Lattuada E, Zappa MA, Roviaro G, Marchesini G, Day CP, Fargion S. Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease.  Gut  2010;59;2  
•  De Alwis N, Hudson G, Burt AD, Day CP, Chinnery PF. Human liver stem cells originate from the canals of Hering.  Hepatology  2009;50;3  
•  Gieling RG, Burt AD, Mann DA. Fibrosis and cirrhosis reversibility - molecular mechanisms.  Clin Liver Dis  2008;12;4  
•  Jones DE, Palmer JM, Burt AD, Kirby JA. The specificity of liver inflammation in mouse models of primary biliary cirrhosis.  Hepatology  2008;48;4  
•  Kirby JA, Robertson H, Marshall HL, Rygiel KA, Hudson M, Jones DE, Burt AD. Epithelial to mesenchymal transition in primary sclerosing cholangitis.  Liver Int.  2008;28;8  
•  Gennery AR, Slatter MA, Rice J, Hoefsloot LH, Barge D, McLean-Tooke A, Montgomery T, Goodship JA, Burt AD, Flood TJ, Abinun M, Cant AJ, Johnson D. Mutations in CHD7 in patients with CHARGE syndrome cause T-B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome.  Clin. Exp. Immunol.  2008;153;1  
•  Newton JL, Jones DE, Henderson E, Kane L, Wilton K, Burt AD, Day CP. Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance.  Gut  2008;57;6  
•  Tiniakos DG, Mathew J, Kittas C, Burt AD. Ontogeny of human intrahepatic innervation.  Virchows Arch.  2008;452;4  

[ See timeline ] [ See all publications ]